Baird Maintains Outperform on Bio-Techne, Raises Price Target to $84
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Catherine Schulte has maintained an Outperform rating on Bio-Techne (NASDAQ:TECH) and raised the price target from $82 to $84.
October 31, 2024 | 11:51 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Baird analyst Catherine Schulte has maintained an Outperform rating on Bio-Techne and increased the price target from $82 to $84, indicating positive sentiment and potential for stock appreciation.
The increase in price target from $82 to $84 by Baird, along with maintaining an Outperform rating, suggests a positive outlook for Bio-Techne. This is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100